NCT01678352
- Conditions
- Glioma, Hemic and Lymphatic Diseases, High Risk WHO Grade II Glioma, +15 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
High Risk WHO Grade II Glioma
Explore clinical trials studying High Risk WHO Grade II Glioma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies